DGX Overview

Key Data

  • Open $134.01
  • Day Range 133.02 - 135.89
  • 52 Week Range 103.26 - 135.89
  • Market Cap $17.34B
  • Shares Outstanding 130.64M
  • Public Float 129.87M
  • Beta 0.72
  • Rev. per Employee $192.59K
  • P/E Ratio 10.31
  • EPS $13.16
  • Yield 1.83%
  • Dividend $0.62
  • Ex-Dividend Date Apr 6, 2021
  • Short Interest 3.61M 04/15/21
  • % of Float Shorted 2.78%
  • Average Volume 1.25M

Performance

5 Day
  • 2.21%
1 Month
  • 5.39%
3 Month
  • 3.23%
YTD
  • 13.47%
1 Year
  • 24.85%

Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 19 Full Ratings

Recent News

  • MarketWatch
  • Dow Jones

Quest Diagnostics upgraded to buy from neutral at UBS

Quest Diagnostics Inc. stock outperforms competitors on strong trading day

Quest Diagnostics Inc. stock outperforms market on strong trading day

Quest Diagnostics Inc. stock falls Thursday, underperforms market

Quest Diagnostics Inc. stock falls Wednesday, underperforms market

Quest Diagnostics Inc. stock outperforms competitors on strong trading day

Quest Diagnostics Inc. stock rises Monday, outperforms market

Quest Diagnostics Inc. stock falls Friday, underperforms market

Quest Diagnostics Inc. stock outperforms competitors on strong trading day

Quest Diagnostics Inc. stock rises Wednesday, still underperforms market

Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors

Quest Diagnostics Inc. stock rises Monday, outperforms market

Quest Diagnostics Inc. stock outperforms market on strong trading day

Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors despite daily gains

Quest Diagnostics Inc. stock falls Wednesday, underperforms market

Quest Diagnostics Inc. stock outperforms competitors despite losses on the day

Quest Diagnostics Inc. stock outperforms competitors on strong trading day

Quest Diagnostics Inc. stock rises Friday, still underperforms market

Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors

Quest Diagnostics Inc. stock falls Wednesday, underperforms market

  • Other News
  • Press Releases

Tuesday’s Top Analyst Upgrades and Downgrades: Alphabet, Bank of America, Boeing, Coinbase, Dollar General, Kroger, McDonald’s and More

on 247WallSt.com

Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?

on Zacks.com

Medical Product Stocks' Earnings on Apr 28: BSX, ALGN & More

on Zacks.com

7 Healthcare Stocks for a Reopening World

on InvestorPlace.com

Quest Diagnostics Inc (DGX) Q1 2021 Earnings Call Transcript

on Motley Fool

Quest Diagnostics (DGX) Q1 Earnings Miss, Base Recovery Strong

on Zacks.com

Quest Diagnostics (DGX) Q1 Earnings Lag Estimates

on Zacks.com

The 7 Best-Performing ETFs Money Can Buy In 2021

on InvestorPlace.com

Molecular Tests to Drive Quest Diagnostics (DGX) Q1 Earnings

on Zacks.com

Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?

on Zacks.com

Quest Diagnostics (DGX) Rides on Test Sales Amid Volume Woe

on Zacks.com

Quest Diagnostics (DGX) Divests Minority Share of Q2 Solutions

on Zacks.com

IQVIA (IQV) Buys Remaining Q2 Solutions Stake, Ups EPS View

on Zacks.com

COVID-19 Resurgence Accelerates Diagnostic Testing: 3 Top Picks

on Zacks.com

Here's Why You Should Retain Quest Diagnostics (DGX) Stock

on Zacks.com

How Biotech Developers Are Working Towards New Diagnostic Solutions to Combat Covid-19

on Baystreet.ca

Thermo Fisher (TMO) Launches Surveillance Tool for COVID-19

on Zacks.com

The Zacks Analyst Blog Highlights: Quest Diagnostics, LabCorp, InMode, Bioanalytical Systems and Semler Scientific

on Zacks.com

Robert Olstein's Olstein Funds 2020 Semiannual Shareholder Letter

on GuruFocus.com

Fed Eyes Faster Recovery in 2021: 3 MedTech Stocks to Buy

on Zacks.com

Quest Diagnostics Inc.

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Competitors

Name Chg % Market Cap
NeoGenomics Inc. -2.08% $5.57B
Laboratory Corp. of America Holdings 1.73% $26.14B
Enzo Biochem Inc. -2.69% $143.24M
Qiagen N.V. -1.03% $10.85B
Psychemedics Corp. 1.93% $37.21M
Sonic Healthcare Ltd. ADR -2.21% $13.25B
Competitor Data Provided ByCapital Cube Logo